Results 21 to 30 of about 2,289,660 (191)

Transcatheter tricuspid valve replacement: will it prevail?

open access: yesFrontiers in Cardiovascular Medicine
Severe tricuspid regurgitation (TR) is a prevalent and challenging condition associated with poor survival outcomes and significant morbidity. Medical therapy alone often fails to provide adequate symptom relief, and stand-alone surgical intervention is ...
Xiling Zhang   +22 more
doaj   +2 more sources

Successful Surgical Tricuspid Valve Repair of Severe Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair [PDF]

open access: yesJACC: Case Reports
Background: Transcatheter edge-to-edge repair has emerged as a minimally invasive option for patients at high surgical risk. Residual/recurrent tricuspid regurgitation (TR) is associated with high morbidity and mortality.
Andreas Winkler, MD   +6 more
doaj   +2 more sources

The Current Landscape of Transcatheter Tricuspid Valve Intervention. [PDF]

open access: yesJ Soc Cardiovasc Angiogr Interv, 2023
Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%.
Seligman H   +10 more
europepmc   +3 more sources

Advanced Carcinoid Tricuspid Valve Disease Associated with Delayed Recognition and Loss of the Interventional Window in a Patient with Ileal Neuroendocrine Tumor: A Case Report [PDF]

open access: yesDiagnostics
Background and Clinical Significance: Carcinoid heart disease remains one of the most serious complications of carcinoid syndrome, yet cardiac involvement may still be recognized late, when valvular damage is already advanced and treatment options are ...
Ionela Cotfas   +4 more
doaj   +2 more sources

State of the art: Transcatheter tricuspid valve intervention. [PDF]

open access: yesJRSM Cardiovasc Dis
Tricuspid regurgitation (TR) has a community prevalence of 3%, which increases with age and affects up to 7% of elderly patients. TR is secondary (functional) in 90% of cases (usually resulting from left heart disease and/or pulmonary hypertension), although atrial dilatation is an increasingly recognised cause.
Wilcox J   +17 more
europepmc   +4 more sources

Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies

open access: yesEuroIntervention, 2018
Moving treanscatheter valve intervention towards atrioventricular (AV) valves implies increasing complexity. Part of the knowledge that has been generated during the development of mitral devices can be transferred to the tricuspid valve (TV).
Maisano, Francesco   +41 more
core   +6 more sources

Unsolved questions in prophylactic tricuspid valve repair and the possible role of transcatheter tricuspid intervention [PDF]

open access: yes, 2020
Tricuspid regurgitation progression after left-sided surgery and its correlation with worse postoperative and long-term outcomes is a highly debated topic.
Tagliari, Ana Paula   +4 more
core   +2 more sources

Surgical outcomes of patients at prohibitive risk who are reconsidered for surgeryCentral MessagePerspective

open access: yesJTCVS Open, 2023
Objectives: Transcatheter treatment of advanced mitral and tricuspid valve disease is largely limited to patients at prohibitive surgical risk, although many are not candidates for transcatheter treatment.
Catherine M. Wagner, MD   +8 more
doaj   +1 more source

Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension [PDF]

open access: yes, 2021
BACKGROUND Scarce data exist on patients with right ventricular dysfunction (RVD) or pulmonary hypertension (PH) undergoing transcatheter tricuspid valve intervention.
Marco Russo   +119 more
core   +1 more source

Home - About - Disclaimer - Privacy